Pfizer CEO Dr. Albert Bourla and Manas AI co-founder Reid Hoffman were among those discussing how health shapes the global ...

Merck KGaA’s long courtship of SpringWorks Therapeutics has come to fruition as the German drugmaker has bought out the ...

After developing treatments for rare tumors, SpringWorks Therapeutics is taking a buyout offer from Germany-based Merck KGaA.

These eight upstart consulting firms are specialized and have an AI-first philosophy, helping them compete with established ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron ...

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...

Indonesian government officials met representatives of giant U.S. companies to talk about plans for TKDN relaxation.

Many doctors recommend routine follow-up tests for cancer patients after they’ve completed a course of treatment, with the ...

Morgan Stanley chief investment officer Michael Wilson believes that the globally dominant U.S. equity market will not break ...

AbbVie had a strong Q1 performance in its oncology, neuroscience, and immunology franchises. Read why I continue to rate ABBV ...

He will be responsible for the oversight of all Pfizer and Allergan's combined commercial businesses, manufacturing and strategy functions. Saunders is understood to have demanded the CEO role in ...